Evidence map›Paper›PMID 29095866›Full record

ArticlePloS one2017

Using data from respondent-driven sampling studies to estimate the number of people who inject drugs: Application to the Kohtla-Järve region of Estonia.

Jiacheng Wu, Forrest W Crawford, Mait Raag, Robert Heimer, Anneli Uusküla

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiacheng WuDepartment of Biostatistics, University of Washington, Seattle, WA, United States of America.
Forrest W CrawfordDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, United States of America.ORCID http://orcid.org/0000-0002-0046-0547
Mait RaagInstitute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
Robert HeimerDepartment of Epidemiology of Microbial Disease and the Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, United States of America.
Anneli UuskülaInstitute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.

Funding

Using Coincidence Analysis to Investigate Factors Affecting PrEP Initiation and Continuation in Southern ending the Epidemic CountiesP30MH062294 · NIMH · YALE UNIVERSITY · PI John Edward Pachankis · 2001 to 2026
$48.5M
Yale University Clinical and Translational Science Award ProgramKL2TR000140 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$2.9M
Influences on HIV Prevalence and Service Access among IDUs in Russia and EstoniaR01DA029888 · NIDA · YALE UNIVERSITY · PI HEIMER, ROBERT, UUSKULA, ANNELI · 2010 to 2014
$2.0M
NCATS NIH HHS KL2 TR000140NIDA NIH HHS R01 DA029888NIMH NIH HHS P30 MH062294
6 · The paper itself

Abstract

Estimating the size of key risk populations is essential for determining the resources needed to implement effective public health intervention programs. Several standard methods for population size estimation exist, but the statistical and practical assumptions required for their use may not be met when applied to HIV risk groups. We apply three approaches to estimate the number of people who inject drugs (PWID) in the Kohtla-Järve region of Estonia using data from a respondent-driven sampling (RDS) study: the standard "multiplier" estimate gives 654 people (95% CI 509-804), the "successive sampling" method gives estimates between 600 and 2500 people, and a network-based estimate that uses the RDS recruitment chain gives between 700 and 2800 people. We critically assess the strengths and weaknesses of these statistical approaches for estimating the size of hidden or hard-to-reach HIV risk groups.

Indexed as

EstoniaHIV InfectionsHumansSampling StudiesSubstance Abuse, Intravenous

Identifiers

PMID29095866
PMCPMC5667832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.